With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting MYCN-amplified Neuroblastoma Through RORalpha Activation||Baylor College of Medicine / Eveline Barbiere, MD||Innovation Grants||2016||Texas|
|Selective Epigenetic Regulation of Notch1 in T-cell Acute Lymphoblastic Leukemia||University of Michigan / Mark Yat-Fung Chiang, MD/PhD||Innovation Grants||2016||Michigan|
|Pre-clinical Testing of Novel Glutamine Metabolic Inhibitors in MYC-driven Medulloblastoma||The Johns Hopkins University School of Medicine / Eric Raabe, MD/PhD & Dr. Barbara Slusher, PhD||Innovation Grants||2016||Maryland|
|CD47-blocking Oncolytic Vaccinia Viruses as Biotherapeutics for Pediatric Solid Tumors||St. Jude Children's Research Hospital / Stephen Gottschalk, MD & Nino Rainusso, MD||Innovation Grants||2016||Tennessee|
|Targeting the Function of Ezrin in Rhabdomyosarcoma||The Cleveland Clinic Foundation / Neetu Gupta, PhD & Peter Anderson, MD||Innovation Grants||2016||Ohio|
|Targeted Combination Therapy to Sensitize High-Risk Acute Lymphoblastic Leukemia to Methotrexate via Restoration of Ikaros Tumor Suppression||The Pennsylvania State University / Sinisa Dovat, MD/PhD & Chunhua Song, MD/PhD||Innovation Grants||2016||Pennsylvania|
|HOX Genes As Developmental Regulators Of Sarcomagenesis||University of Michigan / Elizabeth Lawlor, MD/PhD & Deneen Wellik, PhD||Innovation Grants||2016||Michigan|
|MYC as a Driver and Anti-Cancer Target in Malignant Rhabdoid Tumors||Vanderbilt University Medical Center / William Tansey, PhD||Innovation Grants||2016||Tennessee|
|Enhancing Immunotherapy of Neuroblastoma||The Regents of the University of California, San Diego / Alice Yu, MD/PhD & Mitchell Diccianni, PhD||Innovation Grants||2016||California|
|Development of an anti-KIR3DL1 Antibody to Promote Innate Immunity Against Neuroblastoma||Memorial Sloan-Kettering Cancer Center / Katherine Hsu, MD/PhD & Nai-Kong Cheung, MD/PhD||Innovation Grants||2016||New York|